David Hurlimann
Overview
Explore the profile of David Hurlimann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
1160
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kulling M, Corti R, Noll G, Kuest S, Hurlimann D, Wyss C, et al.
Open Heart
. 2020 Jul;
7(2).
PMID: 32690553
Objective: A multidisciplinary heart valve team is recommended for the evaluation of treatment in patients with valvular heart disease, but evidence supporting this concept is lacking. In patients with severe...
2.
Biaggi P, Sager D, Kulling J, Kuest S, Wyss C, Hurlimann D, et al.
J Am Soc Echocardiogr
. 2020 Mar;
33(4):516-517.e1.
PMID: 32111539
No abstract available.
3.
Salzberg S, van Boven W, Wyss C, Hurlimann D, Reho I, Zerm T, et al.
J Atr Fibrillation
. 2019 May;
11(5):2039.
PMID: 31139293
Background: Traditional surgical treatment for patients with atrial fibrillation (AF) is performed via sternotomy and on cardiopulmonary bypass. It is very effective in regard to rhythm control, but remains unpopular...
4.
Hofer D, Steffel J, Hurlimann D, Haegeli L, Luscher T, Duru F, et al.
J Interv Card Electrophysiol
. 2017 Nov;
50(3):219-226.
PMID: 29177981
Background: Implantable cardioverter defibrillators (ICD) are life-saving device therapy, and patients often carry devices for decades with interim pulse generator exchanges. Inappropriate shocks are associated with impaired quality of life...
5.
Krasniqi N, Segalada D, Luscher T, Lippuner K, Haegeli L, Steffel J, et al.
Cardiol Res Pract
. 2017 Nov;
2017:3297515.
PMID: 29158941
[This corrects the article DOI: 10.1155/2012/498102.].
6.
Kulling M, Kulling J, Wyss C, Hurlimann D, Reho I, Salzberg S, et al.
Eur Heart J Cardiovasc Imaging
. 2017 Jan;
19(1):23-30.
PMID: 28065915
Aims: The Edwards Sapien 3 heart valve prosthesis (S3) is commonly used for transcatheter aortic valve implantation (TAVI) and is available in three sizes. To date no data has been...
7.
Frank M, Ganzoni G, Starck C, Grunenfelder J, Corti R, Gruner C, et al.
Int J Cardiovasc Imaging
. 2015 Dec;
32(3):439-47.
PMID: 26645684
Incomplete information on characteristics of prosthetic heart valves (PHV) may lead to inappropriate choices for PHV implantation (patient-prosthesis-mismatch) or erroneous interpretation of PHV function after implantation. No single and easy...
8.
Hurlimann D, Limacher A, Schabel M, Zanetti G, Berger C, Muhlemann K, et al.
J Antimicrob Chemother
. 2014 Oct;
70(2):602-8.
PMID: 25326088
Objectives: To assess the effectiveness of implementing guidelines, coupled with individual feedback, on antibiotic prescribing behaviour of primary care physicians in Switzerland. Methods: One hundred and forty general practices from...
9.
Hurlimann D, Schmidt S, Seifert B, Saguner A, Hindricks G, Luscher T, et al.
Clin Res Cardiol
. 2014 Oct;
104(2):136-44.
PMID: 25301085
Aims: Various studies have attempted to identify super-responders to cardiac resynchronization therapy (CRT) by echocardiographic parameters of reverse remodeling. However, scientific evidence regarding those parameters is scarce. This study aimed...
10.
Steffel J, Hurlimann A, Starck C, Krasniqi N, Schmidt S, Luscher T, et al.
Indian Pacing Electrophysiol J
. 2014 Jun;
14(3):112-20.
PMID: 24948850
Background: Cardiac resynchronization therapy (CRT) has become an important pillar of contemporary heart failure therapy. The efficacy of CRT, however, critically relies on proper LV lead placement and performance, which...